Lifevantage Corp financial data

Symbol
LFVN on Nasdaq
Industry
Pharmaceutical Preparations
Location
3300 Triumph Blvd, Suite 700, Lehi, UT
Fiscal year end
June 30
Former names
LIFELINE THERAPEUTICS, INC. (to 12/6/2006), YAAK RIVER RESOURCES INC (to 9/28/2004)
Latest financial report
10-Q - Q3 2024 - Oct 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 170 % -13.4%
Quick Ratio 69.1 % -12.9%
Debt-to-equity 128 % +19.6%
Return On Equity 15.3 % +93.8%
Return On Assets 6.73 % +75.8%
Operating Margin 3.14 % +79.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.5M shares -1.39%
Common Stock, Shares, Outstanding 12.5M shares -1.76%
Entity Public Float 68.1M USD +54.1%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 12.2M shares -2.99%
Weighted Average Number of Shares Outstanding, Diluted 12.8M shares -2.17%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 196M USD -7.97%
Research and Development Expense 800K USD +14.3%
Operating Income (Loss) 6.15M USD +65.5%
Nonoperating Income (Expense) -54K USD -121%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6.1M USD +53.4%
Income Tax Expense (Benefit) 1.97M USD +38.7%
Net Income (Loss) Attributable to Parent 4.13M USD +61.5%
Earnings Per Share, Basic 0.34 USD/shares +70%
Earnings Per Share, Diluted 0.32 USD/shares +60%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 16.9M USD -21.8%
Accounts Receivable, after Allowance for Credit Loss, Current 2.97M USD +18.5%
Inventory, Net 16.9M USD +7.69%
Assets, Current 38.8M USD -7.37%
Deferred Income Tax Assets, Net 4.78M USD +1.92%
Property, Plant and Equipment, Net 7.48M USD -19.7%
Operating Lease, Right-of-Use Asset 9.41M USD -4%
Intangible Assets, Net (Excluding Goodwill) 290K USD -31.3%
Other Assets, Noncurrent 685K USD +43.9%
Assets 61.5M USD -7.72%
Accounts Payable, Current 5.27M USD -22.1%
Accrued Liabilities, Current 7.87M USD -0.73%
Contract with Customer, Liability, Current 1.1M USD +10%
Liabilities, Current 22.1M USD -10.6%
Operating Lease, Liability, Noncurrent 11.5M USD -7.98%
Other Liabilities, Noncurrent 225K USD +49%
Liabilities 33.8M USD -9.51%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.13M USD +32%
Retained Earnings (Accumulated Deficit) -109M USD -4.35%
Stockholders' Equity Attributable to Parent 27.7M USD -5.45%
Liabilities and Equity 61.5M USD -7.72%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -583K USD -112%
Net Cash Provided by (Used in) Financing Activities -1.83M USD +72.6%
Net Cash Provided by (Used in) Investing Activities -345K USD +69.6%
Common Stock, Shares Authorized 40M shares 0%
Common Stock, Shares, Issued 12.5M shares -1.76%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.29M USD +28.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 14.6M USD -20.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8K USD
Deferred Tax Assets, Valuation Allowance 720K USD +2.27%
Deferred Tax Assets, Gross 8.55M USD +8.81%
Operating Lease, Liability 13.4M USD -5.36%
Payments to Acquire Property, Plant, and Equipment 349K USD -69.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2.62M USD +681%
Lessee, Operating Lease, Liability, to be Paid 14.5M USD -9.23%
Operating Lease, Liability, Current 1.9M USD +14.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.2M USD +11.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.21M USD +14.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Deferred Income Tax Expense (Benefit) -515K USD +69.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.15M USD -38.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.08M USD +2.82%
Deferred Tax Assets, Operating Loss Carryforwards 271K USD +8.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.77M USD -14%
Operating Lease, Payments 2.16M USD -22.2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 797K USD -13.2%
Share-based Payment Arrangement, Expense 900K USD -10%
Interest Expense 7K USD -50%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%